Innovation of new diagnostic modalities for pancreatic cancer using PET-MRI
Not Applicable
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000016679
- Lead Sponsor
- Fukushima Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1:Patients with contraindication for pilocarpine hydrochloride, such as severe ischemic heart disease, bronchial asthma, ileus, obstruction of urinary tract, epilepsy, Parkinsonism and Parkinson disease, iritis 2:Patients with allegy for indocyanine green
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of PET-MRI for diagnosis of pancreatic cancer compared to PET-CT
- Secondary Outcome Measures
Name Time Method 1)Efficay of elastography and indocyanine green fluorescent pancreatography for diagnosis of pancreatic cancer 2)incidence of pancreatic fistula